Bringing new medicines to the world in areas of unmet medical need now has political as well as scientific and economic dimensions. As a result, there are crucial stakeholders who need to understand the evidence for new therapies: patients and health policy-makers.
A key aspect of the Oxford PharmaGenesis approach to HealthScience is our commitment to developing evidence-based policy initiatives to improve global public health, wherever an unmet medical need exists. We deliver such projects in collaboration with the Oxford Health Policy Forum, the Health Policy Practice of Oxford PharmaGenesis. Their dedicated specialist team works with expert input not only to research and create the core documents, but also to ensure maximum global uptake of the recommendations.
- Government white-paper level policy reports
- Policy research and analysis
- Local stakeholder engagement tools
- Stakeholder advisory panels
- Policy briefing notes and presentations
- Communications and publications plans
Introduction to the Oxford Health Policy Forum
Examples of our work
Fleischhacker W, Arango C, Arteel P et al. Schizophrenia: time to commit to policy change. Oxford PharmaGenesis 2013.
Cowie MR, Anker SD, Cleland J et al. Improving care for patients with acute heart failure: before, during and after hospitalization. Oxford PharmaGenesis 2014.
Giovannoni G, Butzkueven H, Dhib-Jalbut S et al. Brain health: time matters in multiple sclerosis. Oxford: Oxford PharmaGenesis Ltd, 2015.
Oxford PharmaGenesis. MS Brain Health: Time Matters, 2015. Available from: www.msbrainhealth.org (Accessed 12 May 2016).
Ponikowski P, Anker SD, AlHabib KF et al. Heart failure: preventing disease and death worldwide. European Society of Cardiology 2014.